Dr Elizabeth Genovese challenged the reflexive “endo-first” mindset in CLTI and asked a more nuanced question: when should bypass be considered first—and why?
Dr Elizabeth Genovese challenged the reflexive “endo-first” mindset in CLTI and asked a more nuanced question: when should bypass be considered first—and why?
Andrew Holden, MBChB, FRANZCR, delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
Andrew Holden, MBChB, FRANZCR, delivered a comprehensive and forward-looking overview of bioresorbable scaffold technology for BTK disease, with a particular focus on CLTI.
This case report describes 2 different techniques for using percutaneous bypass in patients with prior SFA stent occlusions extending to the common femoral bifurcation.
This case report describes 2 different techniques for using percutaneous bypass in patients with prior SFA stent occlusions extending to the common femoral bifurcation.
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
